#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	450	CRP	633	633	99.53	CRP.l6.c4.ctg.1	1236	27.0	0	.	p	.	0	K29T	NONSYN	85	87	AAG	379	381	ACG	35;35;35	A;C;G	35;35;35	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	1458	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1788	58.2	1	SNP	p	R234F	1	.	.	700	702	TTC	1085	1087	TTC	79;76;75	T;T;C	78;75;75	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	1458	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1788	58.2	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1385	1387	CGT	67;68;69	C;G;T	67;68;69	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	1458	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1788	58.2	0	HET	.	.	.	C996A	.	996	996	C	1381	1381	C	65	C,A	43,22	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	1458	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1788	58.2	0	HET	.	.	.	T999C	.	999	999	T	1384	1384	T	64	T,C	42,22	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	1458	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1788	58.2	0	HET	.	.	.	T180C	.	180	180	T	565	565	T	72	T,C	48,23	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	1458	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1788	58.2	0	HET	.	.	.	C255T	.	255	255	C	640	640	C	82	C,T	41,39	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	742	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1840	30.1	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1531	1533	AAA	21;19;19	A;A;A	21;19;19	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	844	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1907	32.8	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1293	1295	GAA	30;32;34	G;A;A	30;32;34	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	170	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	826	15.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Mycobacterium_chelonae_16S.3003514.NR_114659.1.1_1441.3272	Mycobacterium_chelonae_16S.3003514.NR_114659.1.1_1441.3272	0	0	528	330	Mycobacterium_abscessus_16S+	1441	112	92.86	Mycobacterium_abscessus_16S+.l15.c4.ctg.2	118	25.8	0	.	n	.	0	T293C	SNP	293	293	T	9	9	C	26	C	26	.	Mycobacterium chelonae 16S rRNA mutation conferring resistance to amikacin
Mycobacterium_chelonae_16S.3003514.NR_114659.1.1_1441.3272	Mycobacterium_chelonae_16S.3003514.NR_114659.1.1_1441.3272	0	0	528	330	Mycobacterium_abscessus_16S+	1441	112	92.86	Mycobacterium_abscessus_16S+.l15.c4.ctg.2	118	25.8	0	.	n	.	0	C298T	SNP	298	298	C	14	14	T	40	T	40	.	Mycobacterium chelonae 16S rRNA mutation conferring resistance to amikacin
Mycobacterium_chelonae_16S.3003514.NR_114659.1.1_1441.3272	Mycobacterium_chelonae_16S.3003514.NR_114659.1.1_1441.3272	0	0	528	330	Mycobacterium_abscessus_16S+	1441	112	92.86	Mycobacterium_abscessus_16S+.l15.c4.ctg.2	118	25.8	0	.	n	.	0	C363T	SNP	363	363	C	79	79	T	31	T	31	.	Mycobacterium chelonae 16S rRNA mutation conferring resistance to amikacin
Mycobacterium_chelonae_16S.3003514.NR_114659.1.1_1441.3272	Mycobacterium_chelonae_16S.3003514.NR_114659.1.1_1441.3272	0	0	528	330	Mycobacterium_abscessus_16S+	1441	112	92.86	Mycobacterium_abscessus_16S+.l15.c4.ctg.2	118	25.8	0	.	n	.	0	A372T	SNP	372	372	A	88	88	T	5	T	5	.	Mycobacterium chelonae 16S rRNA mutation conferring resistance to amikacin
Mycobacterium_chelonae_16S.3003514.NR_114659.1.1_1441.3272	Mycobacterium_chelonae_16S.3003514.NR_114659.1.1_1441.3272	0	0	528	330	Mycobacterium_abscessus_16S+	1441	112	92.86	Mycobacterium_abscessus_16S+.l15.c4.ctg.2	118	25.8	0	.	n	.	0	G374T	SNP	374	374	G	90	90	T	ND	ND	ND	.	Mycobacterium chelonae 16S rRNA mutation conferring resistance to amikacin
Mycobacterium_chelonae_16S.3003514.NR_114659.1.1_1441.3272	Mycobacterium_chelonae_16S.3003514.NR_114659.1.1_1441.3272	0	0	528	330	Mycobacterium_abscessus_16S+	1441	112	92.86	Mycobacterium_abscessus_16S+.l15.c4.ctg.2	118	25.8	0	.	n	.	0	T377A	SNP	377	377	T	93	93	A	ND	ND	ND	.	Mycobacterium chelonae 16S rRNA mutation conferring resistance to amikacin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	177	92.66	Pasteurella_multocida_16S.l15.c30.ctg.2	177	32.2	0	.	n	.	0	C990G	SNP	990	990	C	52	52	G	34	G	33	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	177	92.66	Pasteurella_multocida_16S.l15.c30.ctg.2	177	32.2	0	.	n	.	0	T1002A	SNP	1002	1002	T	64	64	A	35	A	35	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	177	92.66	Pasteurella_multocida_16S.l15.c30.ctg.2	177	32.2	0	.	n	.	0	A1004G	SNP	1004	1004	A	66	66	G	35	G	35	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	177	92.66	Pasteurella_multocida_16S.l15.c30.ctg.2	177	32.2	0	.	n	.	0	C1011T	SNP	1011	1011	C	73	73	T	37	T	36	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	177	92.66	Pasteurella_multocida_16S.l15.c30.ctg.2	177	32.2	0	.	n	.	0	C1023A	SNP	1023	1023	C	85	85	A	39	A	38	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	177	92.66	Pasteurella_multocida_16S.l15.c30.ctg.2	177	32.2	0	.	n	.	0	T1024A	SNP	1024	1024	T	86	86	A	40	A	40	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	177	92.66	Pasteurella_multocida_16S.l15.c30.ctg.2	177	32.2	0	.	n	.	0	T1041G	SNP	1041	1041	T	103	103	G	48	G	47	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	177	92.66	Pasteurella_multocida_16S.l15.c30.ctg.2	177	32.2	0	.	n	.	0	A1042T	SNP	1042	1042	A	104	104	T	47	T	46	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	170	G	168	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	170	C	170	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	176	C	176	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	208	T	207	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	222	C	221	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	187	C	185	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	172	A	170	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	161	A	161	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	153	A	152	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	145	T	142	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	142	C	142	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	151	C	147	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	151	A	150	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	150	G	150	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	148	C	147	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	160	T	157	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	157	G,A	155,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	151	G	150	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	152	T	150	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	175	T	175	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	177	G	177	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	173	C	173	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	173	A	172	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	124	C	122	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	108	C	108	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	96	A	95	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	99	A	97	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	97	G,T	96,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	82	C	81	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	95	T	94	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	96	G	95	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	80	T	80	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	159.7	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	232	C	230	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.4	262	46.6	0	.	n	.	0	T50C	SNP	50	50	T	129	129	C	79	C	78	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.4	262	46.6	0	.	n	.	0	G74A	SNP	74	74	G	153	153	A	61	A	61	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.4	262	46.6	0	.	n	.	0	G81.	DEL	81	81	G	159	159	A	46	A	45	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.4	262	46.6	0	.	n	.	0	A83C	SNP	83	83	A	161	161	C	39	C	38	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.4	262	46.6	0	.	n	.	0	T92G	SNP	92	92	T	170	170	G	18	G	18	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.4	262	46.6	0	.	n	.	0	C94.	DEL	94	94	C	171	171	T	18	T,C	13,5	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.4	262	46.6	0	.	n	.	0	T97C	SNP	97	97	T	174	174	C	17	C	17	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.4	262	46.6	0	.	n	.	0	T128C	SNP	128	128	T	205	205	C	28	C	28	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.4	262	46.6	0	.	n	.	0	T135A	SNP	135	135	T	212	212	A	29	A	29	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.4	262	46.6	0	.	n	.	0	G139C	SNP	139	139	G	216	216	C	32	C	32	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.4	262	46.6	0	.	n	.	0	T142G	SNP	142	142	T	219	219	G	34	G	34	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.4	262	46.6	0	.	n	.	0	G159A	SNP	159	159	G	236	236	A	36	A	36	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.4	262	46.6	0	.	n	.	0	G161T	SNP	161	161	G	238	238	T	37	T	37	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.4	262	46.6	0	.	n	.	0	T168G	SNP	168	168	T	245	245	G	34	G	34	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.4	262	46.6	0	.	n	.	0	C170T	SNP	170	170	C	247	247	T	34	T	34	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c30.ctg.4	262	46.6	0	HET	.	.	.	A82G	.	82	82	A	160	160	A	38	A,G	32,5	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	183	92.39	Pasteurella_multocida_16S.l15.c30.ctg.6	183	51.6	0	.	n	.	0	C990G	SNP	990	990	C	59	59	G	45	G	35	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	183	92.39	Pasteurella_multocida_16S.l15.c30.ctg.6	183	51.6	0	.	n	.	0	T1002A	SNP	1002	1002	T	71	71	A	38	A	38	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	183	92.39	Pasteurella_multocida_16S.l15.c30.ctg.6	183	51.6	0	.	n	.	0	A1003C	SNP	1003	1003	A	72	72	C	35	C	35	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	183	92.39	Pasteurella_multocida_16S.l15.c30.ctg.6	183	51.6	0	.	n	.	0	G1008C	SNP	1008	1008	G	77	77	C	33	C,G	32,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	183	92.39	Pasteurella_multocida_16S.l15.c30.ctg.6	183	51.6	0	.	n	.	0	C1011T	SNP	1011	1011	C	80	80	T	33	T	33	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	183	92.39	Pasteurella_multocida_16S.l15.c30.ctg.6	183	51.6	0	.	n	.	0	T1012C	SNP	1012	1012	T	81	81	C	34	C,T	33,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	183	92.39	Pasteurella_multocida_16S.l15.c30.ctg.6	183	51.6	0	.	n	.	0	C1023A	SNP	1023	1023	C	91	91	A	37	A	36	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	183	92.39	Pasteurella_multocida_16S.l15.c30.ctg.6	183	51.6	0	.	n	.	0	.1025G	INS	1025	1025	T	94	94	G	39	G	38	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	183	92.39	Pasteurella_multocida_16S.l15.c30.ctg.6	183	51.6	0	.	n	.	0	T1041G	SNP	1041	1041	T	110	110	G	47	G	47	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	2318	Pasteurella_multocida_16S	1551	183	92.39	Pasteurella_multocida_16S.l15.c30.ctg.6	183	51.6	0	.	n	.	0	A1042T	SNP	1042	1042	A	111	111	T	47	T	47	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	616	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1619	28.4	0	.	p	.	0	H2R	NONSYN	4	6	CAT	240	242	CGT	28;28;28	C,T;G;T	27,1;27;28	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	616	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1619	28.4	0	.	p	.	0	V30I	NONSYN	88	90	GTC	324	326	ATC	35;35;35	A;T;C	35;35;35	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	616	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1619	28.4	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1083	1085	GGC	38;38;39	G;G;C	38;38;39	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	844	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	2303	27.4	0	.	p	.	0	R8S	NONSYN	22	24	AGA	286	288	AGC	19;18;19	A;G;C	19;17;19	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	844	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	2303	27.4	0	.	p	.	0	I142L	NONSYN	424	426	ATA	688	690	CTA	31;33;34	C;T;A	30;33;34	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	844	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	2303	27.4	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1207	1209	CAA	41;41;43	C;A;A	41;41;42	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	844	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	2303	27.4	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1306	1308	GGT	39;39;39	G;G;T	39;38;38	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	844	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	2303	27.4	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1876	1878	GTT	26;26;25	G;T;T	25;25;24	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	352	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1453	17.7	0	.	p	.	0	A125E	NONSYN	373	375	GCA	636	638	GAA	18;18;19	G;A;A	18;18;19	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	352	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1453	17.7	0	.	p	.	0	M185T	NONSYN	553	555	ATG	816	818	ACC	19;19;18	A;C;C	18;19;18	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	352	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1453	17.7	0	.	p	.	0	S225T	NONSYN	673	675	TCC	936	938	ACT	12;11;11	A;C;T	12;11;11	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	352	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1453	17.7	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1326	1328	ATC	10;10;10	A;T;C	10;10;10	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	602	PmrF	969	969	99.38	PmrF.l6.c30.ctg.1	1592	28.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	436	aad-	789	789	100.0	aad-.l15.c4.ctg.1	1403	23.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1644	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3720	33.0	0	.	p	.	0	T85I	NONSYN	253	255	ACC	533	535	ATC	39;39;39	A;T;C	39;39;39	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1644	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3720	33.0	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2246	2248	AAG	33;35;35	A;A;G	33;35;35	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	612	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1778	25.6	0	.	p	.	0	A22V	NONSYN	64	66	GCC	333	335	GTC	21;21;21	G;T;C	21;21;21	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	612	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1778	25.6	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1074	1076	TGC	42;41;43	T;G;C	42;41;43	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1476	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3318	33.2	0	.	p	.	0	S46trunc	TRUNC	136	136	T	401	401	T	32	T	32	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1476	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3318	33.2	0	.	p	.	0	G148D	NONSYN	442	444	GGC	707	709	GAC	52;51;53	G;A;C	51;50;52	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1476	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3318	33.2	0	.	p	.	0	F240L	NONSYN	718	720	TTT	983	985	TTA	23;22;21	T;T;A	23;22;21	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1476	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3318	33.2	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1166	1168	AAT	29;32;32	A;A;T	29;32;32	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1476	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3318	33.2	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1953	1953	T	47	T	46	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	318	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1349	17.7	1	SNP	p	R45C	0	.	.	133	135	CGC	532	534	CGC	36;36;39	C;G;C	36;36;39	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	308	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1053	21.5	0	.	p	.	0	L34F	NONSYN	100	102	CTC	255	257	TTC	28;27;28	T;T;C	28;27;28	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	308	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1053	21.5	0	.	p	.	0	E122G	NONSYN	364	366	GAG	519	521	GGG	30;30;31	G;G;G	30;30;31	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	334	adiY	762	762	99.61	adiY.l6.c30.ctg.1	1275	19.1	0	.	p	.	0	V136L	NONSYN	406	408	GTT	665	667	CTT	32;32;32	C;T;T	32;32;32	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1388	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3203	32.3	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2067	2069	GCA	43;45;45	G;C;A	43;45;44	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1388	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3203	32.3	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2328	2330	ACC	40;40;39	A;C;C	40;40;39	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1388	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3203	32.3	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2637	2639	GCC	46;46;46	G;C;C	45;45;45	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	846	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2570	24.4	0	.	p	.	0	G37A	NONSYN	109	111	GGT	408	410	GCT	20;21;20	G;C;T	20;21;20	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	846	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2570	24.4	0	.	p	.	0	D77E	NONSYN	229	231	GAT	528	530	GAG	27;27;26	G;A;G	27;26;25	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	846	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2570	24.4	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	564	566	TGC	26;23;22	T;G;C	26;22;21	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	846	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2570	24.4	0	.	p	.	0	I150V	NONSYN	448	450	ATT	747	749	GTT	31;31;28	G;T;T	30;30;26	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	846	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2570	24.4	0	.	p	.	0	R200H	NONSYN	598	600	CGC	897	899	CAC	39;40;41	C;A;C	39;40;40	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	846	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2570	24.4	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1182	1184	ATG	43;40;40	A;T;G	43;38;39	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	846	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2570	24.4	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2178	2180	CGC	29;30;30	C;G;C	29;29;30	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	458	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1334	25.6	0	.	p	.	0	S221T	NONSYN	661	663	AGC	1011	1013	ACC	33;33;33	A;C;C	32;32;32	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	458	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1334	25.6	0	.	p	.	0	P225S	NONSYN	673	675	CCG	1023	1025	TCG	32;31;34	T;C;G	32;30;34	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	432	baeR	723	723	97.79	baeR.l15.c17.ctg.1	1483	21.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	544	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1995	20.3	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1426	1428	AAA	16;16;17	A;A;A	15;15;16	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	544	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1995	20.3	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1438	1440	GAG	15;15;15	G;A;G	15;14;15	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	544	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1995	20.3	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1444	1446	CAC	18;18;17	C;A;C	18;18;16	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	544	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1995	20.3	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1498	1500	GAG	14;14;13	G;A;G	14;14;13	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	744	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	2041	26.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	404	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1279	23.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	472	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1366	25.1	0	.	p	.	0	A146T	NONSYN	436	438	GCT	664	666	ACT	38;38;39	A;C;T	38;38;39	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	1	0	27	214	dfrA1_1	474	474	100.0	dfrA1_1.l15.c30.ctg.1	975	16.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	570	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1800	23.3	0	.	p	.	0	I219V	NONSYN	655	657	ATC	1044	1046	GTC	33;33;33	G;T;C	33;33;33	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	888	emrB	1539	1539	99.74	emrB.l6.c30.ctg.1	2224	29.8	0	.	p	.	0	E197K	NONSYN	589	591	GAA	968	970	AAA	46;47;46	A;A;A	46;47;46	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	690	emrD	1191	1191	98.4	emrD.l6.c4.ctg.1	1824	28.2	0	.	p	.	0	G209S	NONSYN	625	627	GGC	899	901	AGC	45;45;44	A;G;C	45;45;44	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	36	emrE_1	333	104	96.15	emrE_1.l6.c30.ctg.1	263	6.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	402	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1783	16.8	0	.	p	.	0	K176R	NONSYN	526	528	AAG	846	848	AGG	19;19;18	A;G;G	19;19;18	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	402	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1783	16.8	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1236	1238	GAC	16;16;16	G;A;C	16;16;16	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	318	emrR	531	531	100.0	emrR.l15.c30.ctg.1	1102	21.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	654	emrY	1539	1539	99.81	emrY.l15.c30.ctg.1	2077	22.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	222	evgA	615	615	99.19	evgA.l15.c30.ctg.1	1163	14.4	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	444	446	CTG	18;18;18	C;T;G	18;18;18	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	T38I	NONSYN	112	114	ACA	374	376	ATA	13;13;13	A;T;A	13;13;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	L42V	NONSYN	124	126	CTA	386	388	GTA	17;18;18	G;T;A	17;18;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	A93T	NONSYN	277	279	GCG	539	541	ACG	20;21;23	A;C;G	20;21;23	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	A114E	NONSYN	340	342	GCA	602	604	GAA	16;16;16	G;A;A	16;16;16	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	T127A	NONSYN	379	381	ACT	641	643	GCT	9;9;9	G;C;T	9;9;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	N133D	NONSYN	397	399	AAT	659	661	GAT	13;13;13	G;A;T	13;13;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	P162S	NONSYN	484	486	CCA	746	748	TCA	16;16;17	T;C;A	16;16;17	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	875	877	CAG	15;15;15	C;A;G	15;15;15	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1013	1015	GTT	18;17;18	G;T;T	18;17;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1169	1171	GAT	19;19;19	G;A;T	18;18;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1337	1339	AAT	9;9;9	A;A;T	8;8;8	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1358	1360	TTA	7;7;7	T;T;A	7;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1559	1561	AAA	10;9;10	A;A;A	10;9;10	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2294	2296	CAT	25;24;25	C;A;T	25;24;25	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2348	2350	CAT	23;22;22	C;A;T	23;22;22	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2366	2368	AGA	19;19;19	A;G;A	19;19;19	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2381	2383	AAT	18;19;19	A;A;T	18;19;19	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2528	2530	TCC	23;22;23	T;C;C	23;22;23	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2693	2695	ATT	24;24;24	A;T;T	24;24;24	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2714	2716	GAT	21;21;21	G;A;T	21;21;21	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2828	2830	GTT	27;26;25	G;T;T	27;26;25	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1130	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4068	20.7	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3113	3115	CAC	22;21;21	C;A;C	21;21;21	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	422	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1363	22.9	1	SNP	p	P64L	0	.	.	190	192	CCA	379	381	CCA	40;40;39	C;C;A	40;40;38	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	422	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1363	22.9	1	SNP	p	P64A	0	.	.	190	192	CCA	379	381	CCA	40;40;39	C;C;A	40;40;38	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	422	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1363	22.9	1	SNP	p	P64R	0	.	.	190	192	CCA	379	381	CCA	40;40;39	C;C;A	40;40;38	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	422	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1363	22.9	1	SNP	p	P64S	0	.	.	190	192	CCA	379	381	CCA	40;40;39	C;C;A	40;40;38	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	422	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1363	22.9	1	SNP	p	P64H	0	.	.	190	192	CCA	379	381	CCA	40;40;39	C;C;A	40;40;38	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	208	gadE	528	528	100.0	gadE.l15.c30.ctg.1	1027	14.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	72	gadW	729	589	94.23	gadW.l15.c17.ctg.1	698	7.3	0	.	p	.	0	E54D	NONSYN	160	162	GAA	20	22	GAT	1;1;1	G;A;T	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	72	gadW	729	589	94.23	gadW.l15.c17.ctg.1	698	7.3	0	.	p	.	0	I88M	NONSYN	262	264	ATA	122	124	ATG	7;7;7	A;T;G	7;7;7	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	72	gadW	729	589	94.23	gadW.l15.c17.ctg.1	698	7.3	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	125	127	CCG	7;7;7	C;C;G	7;7;7	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	72	gadW	729	589	94.23	gadW.l15.c17.ctg.1	698	7.3	0	.	p	.	0	D100E	NONSYN	298	300	GAC	158	160	GAA	5;5;5	G;A;A	5;5;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	72	gadW	729	589	94.23	gadW.l15.c17.ctg.1	698	7.3	0	.	p	.	0	P101S	NONSYN	301	303	CCC	161	163	TCC	5;5;5	T;C;C	5;5;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	72	gadW	729	589	94.23	gadW.l15.c17.ctg.1	698	7.3	0	.	p	.	0	R102G	NONSYN	304	306	CGG	164	166	GGG	5;5;5	G;G;G	5;5;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	72	gadW	729	589	94.23	gadW.l15.c17.ctg.1	698	7.3	0	.	p	.	0	K110N	NONSYN	328	330	AAA	188	190	AAT	3;3;3	A;A;T	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	72	gadW	729	589	94.23	gadW.l15.c17.ctg.1	698	7.3	0	.	p	.	0	S234A	NONSYN	700	702	TCG	560	562	GCG	5;5;5	G;C;G	5;5;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	264	gadX	825	825	97.94	gadX.l15.c17.ctg.1	1134	17.2	0	.	p	.	0	F53L	NONSYN	157	159	TTC	310	312	TTA	16;16;14	T;T;A	16;16;14	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	264	gadX	825	825	97.94	gadX.l15.c17.ctg.1	1134	17.2	0	.	p	.	0	V79I	NONSYN	235	237	GTT	388	390	ATT	17;17;15	A;T;T	17;17;15	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	264	gadX	825	825	97.94	gadX.l15.c17.ctg.1	1134	17.2	0	.	p	.	0	R246G	NONSYN	736	738	AGA	889	891	GGA	20;20;20	G;G;A	20;20;20	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	264	gadX	825	825	97.94	gadX.l15.c17.ctg.1	1134	17.2	0	.	p	.	0	S248P	NONSYN	742	744	TCG	895	897	CCG	19;19;19	C;C;G	19;19;19	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1488	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3282	33.8	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2316	2318	GAA	38;38;37	G;A;A	38;38;37	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1488	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3282	33.8	1	SNP	p	S83I	0	.	.	247	249	TCG	531	533	TCG	42;43;43	T;C;G	42;43;43	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1488	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3282	33.8	1	SNP	p	S83L	0	.	.	247	249	TCG	531	533	TCG	42;43;43	T;C;G	42;43;43	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1488	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3282	33.8	1	SNP	p	S83W	0	.	.	247	249	TCG	531	533	TCG	42;43;43	T;C;G	42;43;43	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1488	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3282	33.8	1	SNP	p	D87V	0	.	.	259	261	GAC	543	545	GAC	42;42;42	G;A;C	42;42;42	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1488	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3282	33.8	1	SNP	p	D87Y	0	.	.	259	261	GAC	543	545	GAC	42;42;42	G;A;C	42;42;42	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1488	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3282	33.8	1	SNP	p	D87G	0	.	.	259	261	GAC	543	545	GAC	42;42;42	G;A;C	42;42;42	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1488	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3282	33.8	1	SNP	p	D87H	0	.	.	259	261	GAC	543	545	GAC	42;42;42	G;A;C	42;42;42	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1488	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3282	33.8	1	SNP	p	D87N	0	.	.	259	261	GAC	543	545	GAC	42;42;42	G;A;C	42;42;42	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1274	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3054	31.3	1	SNP	p	R136G	0	.	.	406	408	CGC	760	762	CGC	41;40;39	C;G;C	41;40;39	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1274	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3054	31.3	1	SNP	p	R136E	0	.	.	406	408	CGC	760	762	CGC	41;40;39	C;G;C	41;40;39	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1274	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3054	31.3	1	SNP	p	R136L	0	.	.	406	408	CGC	760	762	CGC	41;40;39	C;G;C	41;40;39	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1274	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3054	31.3	1	SNP	p	R136H	0	.	.	406	408	CGC	760	762	CGC	41;40;39	C;G;C	41;40;39	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1274	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3054	31.3	1	SNP	p	R136I	0	.	.	406	408	CGC	760	762	CGC	41;40;39	C;G;C	41;40;39	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1274	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3054	31.3	1	SNP	p	R136S	0	.	.	406	408	CGC	760	762	CGC	41;40;39	C;G;C	41;40;39	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1274	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3054	31.3	1	SNP	p	R136C	0	.	.	406	408	CGC	760	762	CGC	41;40;39	C;G;C	41;40;39	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	290	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1034	20.8	0	.	p	.	0	A72P	NONSYN	214	216	GCG	441	443	CCG	31;31;28	C;C;G	31;31;28	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	290	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1034	20.8	0	.	p	.	0	T123A	NONSYN	367	369	ACC	594	596	GCC	17;16;16	G;C;C	16;16;15	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	450	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1419	23.6	0	.	p	.	0	P9S	NONSYN	25	27	CCA	232	234	TCA	23;23;24	T;C;A	23;23;23	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	220	marA	384	384	99.74	marA.l6.c30.ctg.1	892	18.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c4.ctg.1	834	13.2	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	479	481	AGC	19;20;20	A;G;C	19;20;20	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c4.ctg.1	834	13.2	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	581	583	CAT	9;9;9	C;A;T	8;8;9	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c4.ctg.1	834	13.2	1	SNP	p	V45E	0	.	.	133	135	GTG	305	307	GTG	22;22;21	G;T;G	22;22;21	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c4.ctg.1	834	13.2	1	SNP	p	I49S	0	.	.	145	147	ATC	317	319	ATC	21;22;20	A;T;C	21;22;20	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c4.ctg.1	834	13.2	1	SNP	p	A70T	0	.	.	208	210	GCA	380	382	GCA	23;23;23	G;C;A	23;23;23	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c4.ctg.1	834	13.2	1	SNP	p	R73S	0	.	.	217	219	CGT	389	391	CGT	23;23;23	C;G;T	22;23;23	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c4.ctg.1	834	13.2	1	SNP	p	R73C	0	.	.	217	219	CGT	389	391	CGT	23;23;23	C;G;T	22;23;23	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c4.ctg.1	834	13.2	1	SNP	p	R77C	0	.	.	229	231	CGC	401	403	CGC	23;23;23	C;G;C	23;23;23	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c4.ctg.1	834	13.2	1	SNP	p	R77L	0	.	.	229	231	CGC	401	403	CGC	23;23;23	C;G;C	23;23;23	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c4.ctg.1	834	13.2	1	SNP	p	L78M	0	.	.	232	234	CTG	404	406	CTG	22;22;21	C;T;G	22;22;21	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c4.ctg.1	834	13.2	1	SNP	p	R94S	0	.	.	280	282	CGC	452	454	CGC	18;19;18	C;G;C	18;19;18	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c4.ctg.1	834	13.2	1	SNP	p	R94H	0	.	.	280	282	CGC	452	454	CGC	18;19;18	C;G;C	18;19;18	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c4.ctg.1	834	13.2	1	SNP	p	V96E	0	.	.	286	288	GTA	458	460	GTA	21;21;21	G;T;A	21;21;21	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	558	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1815	22.7	0	.	p	.	0	S7F	NONSYN	19	21	TCC	279	281	TTC	15;15;16	T;T;C	15;15;16	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	558	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1815	22.7	0	.	p	.	0	R36I	NONSYN	106	108	AGG	366	368	ATC	10;10;10	A;T;C	10;10;10	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	558	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1815	22.7	0	.	p	.	0	E42A	NONSYN	124	126	GAA	384	386	GCC	9;12;13	G;C;C	9;12;13	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	558	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1815	22.7	0	.	p	.	0	N43V	NONSYN	127	129	AAT	387	389	GTG	13;13;13	G;T;G	13;13;13	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	558	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1815	22.7	0	.	p	.	0	E52D	NONSYN	154	156	GAG	414	416	GAT	11;10;10	G;A;T	11;10;10	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	558	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1815	22.7	0	.	p	.	0	N59T	NONSYN	175	177	AAC	435	437	ACC	13;12;12	A;C;C	12;12;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	558	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1815	22.7	0	.	p	.	0	I68L	NONSYN	202	204	ATA	462	464	TTA	11;11;11	T;T;A	11;11;10	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	558	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1815	22.7	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	603	605	CAG	44;44;43	C;A;G	44;44;43	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	558	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1815	22.7	0	.	p	.	0	D128A	NONSYN	382	384	GAC	642	644	GCC	34;34;34	G;C;C	34;34;34	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	558	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1815	22.7	0	.	p	.	0	S163A	NONSYN	487	489	TCG	747	749	GCG	38;38;38	G;C;G	38;38;38	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	558	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1815	22.7	0	.	p	.	0	L231V	NONSYN	691	693	CTT	951	953	GTT	38;38;39	G;T;T	32;35;35	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	558	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1815	22.7	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1113	1113	C	41	C	41	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	440	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1700	19.3	0	.	p	.	0	V12trunc	TRUNC	34	34	G	218	218	G	12	G	12	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	440	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1700	19.3	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	275	277	CAG	9;9;9	C;A;G	9;9;9	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	440	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1700	19.3	0	.	p	.	0	T83I	NONSYN	247	249	ACC	425	427	ATC	14;14;16	A;T;C	14;14;16	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	440	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1700	19.3	0	.	p	.	0	I99M	NONSYN	295	297	ATA	473	475	ATG	16;16;17	A;T;G	16;16;16	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	440	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1700	19.3	0	.	p	.	0	A130T	NONSYN	388	390	GCC	566	568	ACC	19;19;18	A;C;C	19;19;18	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	440	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1700	19.3	0	.	p	.	0	P257T	NONSYN	769	771	CCG	947	949	ACG	28;27;27	A;C;G	28;27;27	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1586	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3784	31.3	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2157	2159	ACC	39;41;41	A;C;C	39;41;41	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1586	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3784	31.3	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2550	2552	CAA	26;26;26	C;A;A	26;26;26	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1586	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3784	31.3	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2718	2720	ATT	30;30;29	A;T;T	30;30;28	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1586	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3784	31.3	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2802	2804	GTT	32;33;33	G;T;T	32;32;33	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1586	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3784	31.3	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2910	2912	GAG	37;37;37	G;A;G	37;37;37	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1586	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3784	31.3	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3138	3140	ATG	32;31;31	A;T;G	32;31;31	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1586	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3784	31.3	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3273	3275	GAT	26;25;27	G;A;T	26;25;27	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1616	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3654	32.8	0	.	p	.	0	I46M	NONSYN	136	138	ATC	451	453	ATG	20;20;19	A;T;G	19;20;19	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1616	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3654	32.8	0	.	p	.	0	V208I	NONSYN	622	624	GTC	937	939	ATC	39;38;38	A;T;C	39;37;37	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1616	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3654	32.8	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3253	3255	CAC	21;21;21	C;A;C	21;20;20	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1616	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3654	32.8	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3256	3258	CTC	21;21;20	C;T;C	20;20;19	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	768	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	2009	28.5	0	.	p	.	0	D3E	NONSYN	7	9	GAT	315	317	GAA	20;19;19	G;A;A	20;18;19	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	768	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	2009	28.5	0	.	p	.	0	T226A	NONSYN	676	678	ACG	984	986	GCG	37;38;38	G;C;G	37;38;38	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	768	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	2009	28.5	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1326	1328	ATC	25;26;27	A;T;C	25;26;27	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	768	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	2009	28.5	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1629	1631	TTT	36;36;35	T;T;T	36;36;35	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	760	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1913	29.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1636	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3734	32.9	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1223	1225	ACC	34;33;32	A;C;C,A	34;32;30,2	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1636	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3734	32.9	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2465	2467	GAC	41;41;41	G;A;C	41;41;41	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	785	582	mdtG	1227	1227	99.33	mdtG.l6.c30.ctg.1	2223	19.3	0	.	p	.	0	E5G	NONSYN	13	15	GAA	402	404	CAC	10;10;10	C;A;C	10;10;10	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	785	582	mdtG	1227	1227	99.33	mdtG.l6.c30.ctg.1	2223	19.3	0	.	p	.	0	V200I	NONSYN	598	600	GTC	1250	1252	ATC	23;23;25	A;T;C	23;23;25	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	682	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1649	30.8	0	.	p	.	0	G134C	NONSYN	400	402	GGT	622	624	TGT	36;36;35	T;G;T	36;36;35	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	682	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1649	30.8	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1192	1194	TTG	39;38;38	T;T;G	39;38;38	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	682	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1649	30.8	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1402	1404	ACG	27;27;27	A;C;G	26;26;26	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	692	mdtL	1176	1176	98.38	mdtL.l15.c4.ctg.1	1972	26.0	0	.	p	.	0	A185S	NONSYN	553	555	GCC	939	941	TCC	17;17;17	T;C;C	14;17;17	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	442	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1560	20.8	0	.	p	.	0	V119I	NONSYN	355	357	GTT	545	547	ATT	32;33;33	A;T;T	32;33;33	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	988	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2625	28.0	0	.	p	.	0	V11M	NONSYN	31	33	GTG	361	363	ATG	24;24;25	A;T;G	24;24;25	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	988	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2625	28.0	0	.	p	.	0	T33I	NONSYN	97	99	ACC	427	429	ATC	20;20;20	A;T;C	20;20;20	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	988	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2625	28.0	0	.	p	.	0	C116R	NONSYN	346	348	TGC	676	678	CGC	39;40;40	C;G;C	39;40;40	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	988	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2625	28.0	0	.	p	.	0	N238S	NONSYN	712	714	AAC	1042	1044	AGC	32;32;35	A;G;C	32;32;35	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	988	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2625	28.0	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1243	1245	GTG	24;24;23	G;T;G	24;23;23	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	988	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2625	28.0	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1306	1308	AAC	13;13;13	A;A;C	10;9;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	988	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2625	28.0	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1351	1353	GTC	26;25;25	G,C;T,C;C	25,1;23,1;25	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	988	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2625	28.0	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1381	1383	ATA	28;28;28	A;T;A	28;28;28	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	988	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2625	28.0	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1489	1491	TCT	27;27;28	T;C;T	27;26;27	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	988	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2625	28.0	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1876	1878	GCG	34;32;34	G;C;G	34;32;34	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	988	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2625	28.0	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	2089	2091	ATC	25;27;26	A;T;C	25;27;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	606	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1840	24.5	0	.	p	.	0	S129A	NONSYN	385	387	TCA	650	652	GCG	29;29;32	G;C;G	29;29;32	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	606	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1840	24.5	0	.	p	.	0	A187T	NONSYN	559	561	GCC	824	826	ACC	34;34;33	A;C;C	34;33;33	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	606	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1840	24.5	0	.	p	.	0	H211R	NONSYN	631	633	CAC	896	898	CGC	34;34;34	C;G;C	34;34;33	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	606	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1840	24.5	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1013	1015	GCT	31;31;31	G;C;T	31;31;31	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	606	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1840	24.5	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1097	1099	AAA	22;20;20	A;A;A	22;20;20	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	606	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1840	24.5	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1115	1117	CGA	11;11;11	C;G;A	11;11;11	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	606	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1840	24.5	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1280	1282	GCC	25;26;26	G;C;C	25;26;26	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	606	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1840	24.5	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1292	1294	GAT	25;26;26	G;A;T	25;26;26	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	606	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1840	24.5	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1709	1711	GCT	15;15;16	G;C;T	15;15;16	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1700	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3953	31.9	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1580	1582	AAG	21;20;21	A;A;G	21;20;21	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1700	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3953	31.9	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2657	2659	CTG	35;35;36	C;T;G	35;35;36	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	144	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	805	13.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	934	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2188	31.7	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1040	1042	AAC	34;34;33	A;A;C	34;34;33	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	934	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2188	31.7	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1586	1588	ATA	38;38;38	A;T;A	38;38;38	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	756	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1865	30.3	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1388	1390	GAT	40;40;41	G;A;T	39;39;40	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	756	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1865	30.3	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1391	1393	CTG	42;42;42	C;T;G	41;40;41	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	410	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1386	22.1	0	.	p	.	0	R27C	NONSYN	79	81	CGT	406	408	TGT	31;30;31	T;G;T	30;30;31	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	410	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1386	22.1	0	.	p	.	0	I117T	NONSYN	349	351	ATC	676	678	ACC	32;32;32	A;C;C	31;32;32	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	410	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1386	22.1	0	.	p	.	0	G187D	NONSYN	559	561	GGC	886	888	GAC	35;34;33	G;A;C	35;34;33	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	410	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1386	22.1	1	SNP	p	R15C	0	.	.	43	45	CGC	370	372	CGC	44;43;44	C;G;C	44;43;44	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	410	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1386	22.1	1	SNP	p	S33R	0	.	.	97	99	AGC	424	426	AGC	31;31;32	A;G;C	31;31;32	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	410	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1386	22.1	1	SNP	p	G131D	0	.	.	391	393	GGC	718	720	GGC	36;35;36	G;G;C	36;35;35	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	410	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1386	22.1	1	SNP	p	R203L	0	.	.	607	609	CGT	934	936	CGT	26;26;25	C;G;T	26;26;25	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	410	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1386	22.1	1	SNP	p	R203C	0	.	.	607	609	CGT	934	936	CGT	26;26;25	C;G;T	26;26;25	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	624	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1605	28.8	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1180	1182	GAG	36;35;34	G;A;G	36;35;34	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	624	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1605	28.8	1	SNP	p	G141D	0	.	.	421	423	GGT	667	669	GGT	36;36;36	G;G;T	35;35;36	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	624	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1605	28.8	1	SNP	p	G141E	0	.	.	421	423	GGT	667	669	GGT	36;36;36	G;G;T	35;35;36	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	624	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1605	28.8	1	SNP	p	R154A	0	.	.	460	462	CGT	706	708	CGT	44;45;45	C;G;T	44;45;45	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	624	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1605	28.8	1	SNP	p	R154D	0	.	.	460	462	CGT	706	708	CGT	44;45;45	C;G;T	44;45;45	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1268	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2832	33.3	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1943	1945	GTG	47;48;48	G;T;G	46;47;47	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1268	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2832	33.3	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1970	1972	TCG	42;42;44	T;C;G	40;41;44	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1268	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2832	33.3	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2585	2587	AAC	19;18;18	A;A;C	19;18;18	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1268	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2832	33.3	1	SNP	p	A85T	0	.	.	253	255	GCG	599	601	GCG	34;34;32	G;C;G	34;34;31	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1268	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2832	33.3	1	SNP	p	D111H	0	.	.	331	333	GAT	677	679	GAT	37;39;40	G;A;T	37;39;40	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1268	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2832	33.3	1	SNP	p	S129P	0	.	.	385	387	TCC	731	733	TCC	34;34;34	T;C;C	34;34;34	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	904	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2530	26.8	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1684	1686	AAC	31;30;31	A;A;C	31;30;31	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	904	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2530	26.8	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1693	1695	GAT	36;35;37	G;A;T	36;34;37	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	912	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1972	34.4	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	889	891	CAG	45;46;47	C;A;G	45;46;47	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	912	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1972	34.4	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1363	1365	GAT	48;48;50	G;A;T	48;47;50	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2150	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4702	34.0	1	SNP	p	V146F	0	.	.	436	438	GTT	731	733	GTT	39;39;39	G;T;T	39;39;39	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2150	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4702	34.0	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1832	1834	CAG	32;33;33	C;A;G	32;33;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2150	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4702	34.0	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1832	1834	CAG	32;33;33	C;A;G	32;33;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2150	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4702	34.0	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1871	1873	CAC	36;36;37	C;A;C	36;35;35	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2150	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4702	34.0	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1880	1882	CGT	40;39;39	C;G;T	39;39;39	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2150	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4702	34.0	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1880	1882	CGT	40;39;39	C;G;T	39;39;39	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2150	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4702	34.0	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1886	1888	TCC	41;42;43	T;C;C	40;42;43	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2150	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4702	34.0	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1892	1894	CTC	39;39;40	C;T;C	38;39;39	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2150	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4702	34.0	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1982	1984	ACC	34;36;35	A;C;C	34;36;35	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2150	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4702	34.0	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1985	1987	CCT	34;34;33	C;C;T	34;34;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2150	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4702	34.0	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2354	2356	CGT	74;75;77	C;G;T	74;75;77	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	0	.	n	.	0	A226G	SNP	226	226	A	364	364	G	312	G	311	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	1	SNP	n	A794G	0	.	.	794	794	A	932	932	A	327	A	324	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	1	SNP	n	A794T	0	.	.	794	794	A	932	932	A	327	A	324	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	1	SNP	n	G926A	0	.	.	926	926	G	1064	1064	G	314	G	313	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	1	SNP	n	G926T	0	.	.	926	926	G	1064	1064	G	314	G	313	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	1	SNP	n	G926C	0	.	.	926	926	G	1064	1064	G	314	G	313	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	1	SNP	n	A1519C	0	.	.	1519	1519	A	1657	1657	A	157	A	157	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	1	SNP	n	A1519G	0	.	.	1519	1519	A	1657	1657	A	157	A	157	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	1	SNP	n	A1519T	0	.	.	1519	1519	A	1657	1657	A	157	A	157	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	0	HET	.	.	.	C183T	.	183	183	C	321	321	C	282	C,T	176,104	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	0	HET	.	.	.	T90C	.	90	90	T	228	228	T	275	T,C	204,70	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	0	HET	.	.	.	A250T	.	250	250	A	388	388	A	287	A,T	214,72	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	0	HET	.	.	.	G474A	.	474	474	G	612	612	G	303	G,A	223,79	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	0	HET	.	.	.	A253T	.	253	253	A	391	391	A	292	A,T	218,72	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	0	HET	.	.	.	C1038T	.	1038	1038	C	1176	1176	C	339	C,T	206,130	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	0	HET	.	.	.	C194T	.	194	194	C	332	332	C	291	C,T	219,69	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	0	HET	.	.	.	C719T	.	719	719	C	857	857	C	308	C,T	179,128	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	0	HET	.	.	.	G1002A	.	1002	1002	G	1140	1140	G	295	G,A	168,124	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	0	HET	.	.	.	G1006C	.	1006	1006	G	1144	1144	G	306	G,C	176,125	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	0	HET	.	.	.	A79G	.	79	79	A	217	217	A	285	A,G	210,73	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	0	HET	.	.	.	T273A	.	273	273	T	411	411	T	293	T,A	223,69	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7268	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1693	299.0	0	HET	.	.	.	T1010C	.	1010	1010	T	1148	1148	T	294	T,C	171,121	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	338	sat_1	525	525	100.0	sat_1.l15.c4.ctg.1	1028	24.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli;sat-1
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	434	soxR	465	465	100.0	soxR.l15.c30.ctg.1	1096	29.4	1	SNP	p	R20H	0	.	.	58	60	CGC	442	444	CGC	55;56;56	C;G;C	55;56;55	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	434	soxR	465	465	100.0	soxR.l15.c30.ctg.1	1096	29.4	1	SNP	p	G121D	0	.	.	361	363	GGT	745	747	GGT	47;47;45	G;G;T	47;46;45	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	276	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	1055	19.2	1	SNP	p	A12S	0	.	.	34	36	GCA	415	417	GCA	54;54;52	G;C;A	54;54;51	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	27	500	APH_3____Ib+	804	804	100.0	APH_3____Ib+.l15.c30.ctg.1	1459	25.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	27	546	APH_6__Id+	837	837	100.0	APH_6__Id+.l15.c4.ctg.1	1550	26.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	27	382	sul2	816	816	100.0	sul2.l15.c4.ctg.1	1318	21.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	598	tetA	1200	1200	100.0	tetA.l15.c4.ctg.1	1556	27.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	338	tetR	651	651	100.0	tetR.l15.c4.ctg.1	1152	21.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	830	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	2122	29.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
